India’s Supreme Court Rules Doxofylline Is A Derivative Of Theophylline; Favors Price Controls
This article was originally published in PharmAsia News
Executive Summary
In a verdict that could potentially bring up more disputes, the India Supreme Court held that asthma drug doxofylline should be considered for price ceilings.